TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
St1 Biokraft AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
42,280
|
451,640
|
346,875 |
| Financial expenses |
100,915
|
117,351
|
55,798 |
| Earnings before taxes |
-436,063
|
-174,602
|
-90,211 |
| EBITDA |
-64,142
|
22,686
|
17,770 |
| Total assets |
2,001,688
|
1,987,182
|
1,772,766 |
| Current assets |
219,196
|
448,709
|
614,254 |
| Current liabilities |
373,327
|
356,060
|
243,646 |
| Equity capital |
743,674
|
587,484
|
702,666 |
| - share capital |
89,886
|
88,294
|
82,444 |
| Employees (average) |
45
|
115
|
105 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
37.2%
|
29.6%
|
39.6% |
| Turnover per employee |
940
|
3,927
|
3,304 |
| Profit as a percentage of turnover |
-1031.4%
|
-38.7%
|
-26.0% |
| Return on assets (ROA) |
-16.7%
|
-2.9%
|
-1.9% |
| Current ratio |
58.7%
|
126.0%
|
252.1% |
| Return on equity (ROE) |
-58.6%
|
-29.7%
|
-12.8% |
| Change turnover | |||
| Change turnover % |
22%
|
-7% | |
| Chg. No. of employees | |||
| Chg. No. of employees % |
10%
|
-4% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.